page 1 memorandum department of health and human services public service food drug administration center for evaluation research pid d040001 date april 6 2005 from michael c evans r ph pharmacist use specialist division surveillance communication support hfd 410 andrea feight dmd mph epidemiologist through gerald dal pan md mhs director to solomon iyasu pediatric development 960 office counter terrorism subject one year post exclusivity marketing adverse event review data trusopt dorzolamide hydrochloride nda 20 408 approval january 5 2004 this document contains proprietary ims caremark which cannot be shared outside the fda without clearance safety ___________________________________________________________________________________________ executive summary consult examines trends in population 0 16 years with primary focus on patterns before following granting total dispensed prescriptions
